Armata Pharmaceuticals Files 2024 10-K
Ticker: ARMP · Form: 10-K · Filed: Mar 21, 2025 · CIK: 921114
| Field | Detail |
|---|---|
| Company | Armata Pharmaceuticals, INC. (ARMP) |
| Form Type | 10-K |
| Filed Date | Mar 21, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, financials, pharmaceuticals
TL;DR
Armata Pharma's 2024 10-K is in. Check financials for 22-24.
AI Summary
Armata Pharmaceuticals, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, formerly AmpliPhi Biosciences Corp, is based in Los Angeles, California. The filing details its financial position and business operations, including information on retained earnings, additional paid-in capital, and common stock for the years 2022, 2023, and 2024.
Why It Matters
This filing provides investors with a comprehensive overview of Armata Pharmaceuticals' financial health and operational status as of the end of 2024, crucial for evaluating investment potential.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Armata Pharmaceuticals is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2023-12-31 — Fiscal Year End (Prior year financial data included)
- 2022-12-31 — Fiscal Year End (Data from two years prior included)
Key Players & Entities
- Armata Pharmaceuticals, Inc. (company) — Filer of the 10-K
- AmpliPhi Biosciences Corp (company) — Former name of Armata Pharmaceuticals
- 2024-12-31 (date) — Fiscal year end
- 2022-12-31 (date) — Fiscal year end
- 2023-12-31 (date) — Fiscal year end
FAQ
What is the primary business of Armata Pharmaceuticals, Inc.?
Armata Pharmaceuticals, Inc. is in the business of Biological Products (No Diagnostic Substances), as indicated by its SIC code 2836.
When did Armata Pharmaceuticals, Inc. change its name from AmpliPhi Biosciences Corp?
The company changed its name from AmpliPhi Biosciences Corp on February 22, 2013.
What is the business address of Armata Pharmaceuticals, Inc.?
The business address is 5005 McConnell Ave, Los Angeles, CA 90066.
What fiscal years are covered by the financial data presented in this 10-K?
The financial data presented covers the fiscal years ending December 31, 2024, December 31, 2023, and December 31, 2022.
What are some of the financial statement components mentioned in the filing?
The filing mentions Retained Earnings, Additional Paid-In Capital, and Common Stock for the fiscal years 2022, 2023, and 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 21, 2025 regarding Armata Pharmaceuticals, Inc. (ARMP).